This event will bring together the full range of stakeholders and influencers in the orphan drug and rare disease sector, from the pharma and biotechs to patient advocates and representatives from payers to review recent developments in the orphan drug and rare diseases industry, to learn and discuss the most pressing topics, benchmark best practices with their peers and discover the future of orphan drug research, development and manufacture.
The Summit will be focusing on the strategic and commercial aspects of bringing new treatments to patients who suffer from rare diseases.
Our experts will be leading discussions covering how payers, pharmaceutical, biotech, patient organisations and academia are structuring to participate in and leverage the growing orphan drugs and rare diseases market.
It is an honor and privilege to invite you to participate in this Summit. We look forward to welcome you in Barcelona upcoming March!
Key Practical Learning Points of the Summit:
Why should you be there?
Who should attend?
2 March 2017 @ 08:30
3 March 2017 @ 05:00
Duration: 1 days, 8 hours
Curtis Wyss (view profile)